K-Ras proteins transduce signals from membrane-bound receptors via multiple downstream effector pathways and thereby regulate fundamental stem cell processes that affect neoplasia, including proliferation, apoptosis, and differentiation, but their contribution to tumourigenesis is unclear. Because cancers develop from stem cells, we set out to determine the characteristic changes in gene expression brought about by mutated K-ras (without interference from normal K-ras) in otherwise normal stem cells. cDNA microarrays were used to analyze gene expression profiles comparing wild-type murine embryonic stem (ES) cells with K-ras
INTRODUCTION
Cancer cells acquire multiple genetic and epigenetic alterations often involving activation of protooncogenes, including the ras gene family (11, 16, 28, 38) . Ras proteins function as plasma membranebound GTPases and act as molecular switches by regulating receptor-signal transduction pathways, including the Raf/MEK/ERK (MAPK) and PI3-K/Akt kinase cascades, and so affect diverse functions, including stem cell proliferation, differentiation, and 1 apoptosis (7, 9, 42) . Activating point mutations that lead to constitutive activation of Ras proteins by stabilizing the active GTP-bound configuration are prevalent in some 30% of human malignancies, with K-ras mutations found in lung (30%), colorectal (40-50%) , and pancreatic (90%) cancers (1, 7) . The presence of K-ras activating mutations in early neoplastic lesions, including intestinal aberrant crypt foci (12) , suggests an early stage of involvement in carcinogenesis and expression of mutated endogenous K-ras in mouse models promotes intestinal, kidney, lung, and 2 LUO ET AL. pancreatic tumor formation (18, 35, 40) . The codon 12 valine mutant of K-ras has been shown to be the only K-ras mutation to be associated with a poorer patient survival and increased chance of cancer recurrence in patients with colorectal cancers bearing a K-ras mutation (3,4). Compared to our knowledge of K-ras signaling events, little is known about the key target genes whose expression levels are altered as a result of K-ras activation.
Because tumors can derive from tissue stem cells and may harbor "cancer stem cells" (2), we hypothesized that expression of mutated K-ras might contribute to early neoplastic development and progression by modulating the expression levels of target genes in stem cells that affect proliferation, apoptosis or stem cell self-renewal versus differentiation. Embryonic stem (ES) cells are an appropriate model for investigation of the effects of oncogenic K-ras on gene expression and stem cell processes. We used ES cell lines containing changes to the K-ras gene only, with no other cancer-related mutations, thus avoiding many of the problems of analyzing immortalized or cancer cell lines. These were derived from wild-type murine embryonic stem cells (HM1), by knocking out exons 1-3 of both alleles of K-ras to generate K-rasnull (K-ras −/− ) ES cells. The K-ras −/− ES cells were further manipulated to stably reexpress oncogenically activated K-ras
Val12
, by transfecting them with an expression vector containing a human K-ras minigene with an activating valine (for glycine) substitution at codon 12 (9) . These genetic manipulations were designed so that we could study the transcriptomemodulating effects of K-Ras Val12 proteins without interference by competing wild-type K-Ras proteins. Thus, we used cDNA microarray technology to analyze changes in the gene expression profiles of Kras Val12 expressing ES cells, compared to wild-type ES cells, in order to identify genes that mediate or modulate K-ras
-induced phenotypic effects on stem cells.
MATERIALS AND METHODS

Cell Culture
This study employed two embryonic stem cell lines, one of them was a wild-type murine ES cell line (HM1), the other ES cell line was derived by targeted knocking out of both endogenous K-ras alleles and then introduction of an expression vector with a mutant human K-ras Val12 minigene as described previously (9) . ES cell lines were maintained as monolayer cultures in gelatin-treated flasks at 37°C in 5% CO 2 and 95% air incubator in GMEM supplemented with 1 mM nonessential amino acids, 2 mM glutamine, 1 mM sodium pyruvate, 10% fetal calf serum (FCS), 0.1 mM 2-mercaptoethanol, and 1000 U/ ml recombinant leukemia inhibitory factor (LIF).
Measurement of Alkaline Phosphatase Activity of ES Cells
ES cells (at ϳ70% confluence) were treated with 0.25% trypsin to harvest a single-cell suspension, and these were seeded at 1 × 10 4 cells per well on gelatinized six-well plates with 3 ml ES media containing between 0-1000 U/ml LIF. After 6 days of culture, alkaline phosphatase activity was determined using the ALP-10 kit (Sigma-Aldrich, UK) following the manufacturer's instructions. Briefly, the ES cell populations were washed twice in PBS, lysed in 0.1% Triton X for 5 min prior to addition of the nitrophenylphosphate buffer. All reactions were performed in situ on 96-well spectra plates (Falcon, UK) and the reaction rates were determined by taking absorbency readings at 405 nm at 37°C with a spectrophotometer over a 15-min period at 1-min intervals.
Stem Cell Self-Renewal Versus Differentiation Assay
ES cells were maintained on feeder-free gelatincoated plates in FCS-containing medium supplemented with LIF: Glasgows minimal essential medium (GMEM; Sigma-Aldrich, UK), supplemented with 10% FCS (selected batches, Sigma-Aldrich), 100 µM 2-mercaptoethanol (Nacalai Tesque, UK), 1× nonessential amino acids (Invitrogen, UK), 1 mM sodium pyruvate (Invitrogen), and 1000 U/ml LIF (Sigma-Aldrich). ES cells were seeded onto gelatincoated six-well plates at a density of 1 × 10 3 cells/ well and cultured for 6 days in the presence of 10, 100, or 500 U/ml LIF. Alkaline phosphatase staining was carried out using BCIP/NBT solution (SigmaAldrich) following the manufacturer's instructions. Up to 200 colonies were counted and scored for positivity or negativity for alkaline phosphatase staining, and the proportion of self-renewing, undifferentiated, alkaline phosphatase-positive ES colonies was calculated.
Measurement of Apoptosis After Treatment of Cells With DNA-Damaging Agents
The ES cells were treated with etoposide, which was dissolved in DMSO to a stock concentration of 100 mM before diluting into growth medium at the indicated concentrations. After 24-h treatment, the ES cells were harvested and stained with propidium iodide (41) . Analysis was performed on a Coulter EPICS-XL flow cytometer and the proportion of apoptotic cells taken as the proportion of DNA in the sub-G 1 /G 0 (or hypodiploid) peak. To confirm the data EXPRESSION CHANGES IN K-rasVal12 ES CELLS 3 from flow cytometry, cells were harvested and stained with acridine orange. The proportions of apoptotic cells were measured by observation of nuclear morphological changes characteristic of apoptosis using florescence microscopy, identifying chromatin condensation and nuclear fragmentation. These data correlated strongly with hypodiploid peak data from flow cytometric analysis.
RNA Isolation and Microarray Hybridization
The ES cell cultures were harvested when 70-80% confluent. Total RNA was isolated by Trizol (Invitrogen). Briefly, stem cells were washed with cold PBS twice, 1 ml Trizol reagent was added, and the solution was incubated at room temperature for 2-3 min; chloroform was added and the phases were separated, and then isopropanol precipitated RNA was recovered from the aqueous phase. The RNA pellet was resuspended in nuclease-free water and purified by using the RNeasy Mini Kit (Qiagen). RNA was quantified using spectrophotometric measurement of the ratio at 260/280 nm and by 1% agarose gel electrophoretic analysis. For generating fluorescently labeled cDNA probes, we used the FluoroScript TM cDNA Labelling System (Invitrogen) to transcribe total RNA. Briefly, 1000 pmol of oligo d(T) [12] [13] [14] [15] [16] [17] [18] primer and 100 pmol antisense PCR primer of 18S rRNA were mixed with 80 µg of total RNA in a final volume of 15.4 µl. The reaction mixture was incubated at 70°C for 10 min, quenched on ice for 5 min, and then 14.6 µl of labeling mix [1× first-strand cDNA synthesis buffer, 10 mM DTT, 0.5 mM each of dATP, dGTP, and dTTP, 0.2 mM dCTP, 3 µl Cy3-or Cy5-dCTP (Amersham Pharmacia Biotech), and 2 µl Superscript II] were added and the reaction incubated at 42°C for 2 h in the dark. Labeled cDNA was purified on an AutoSeq G-50 column (Amersham Pharmacia Biotech); the Cy5 and Cy3 samples were then pooled and precipitated with ethanol. The microarray slides were obtained from the Human Genome Mapping Project Resource Centre, MRC Rosalind Franklin Centre for Genomics Research (Hixton, Cambridge, UK) and array description files were downloaded from http://www.mrc.ac.uk. The Mouse NIA Clone Set Arrays (version 2) included about 15,000 cDNAs on two slides. Labeled probes were resuspended in 35 µl of hybridization buffer (50% formamide, 5× SSC, 5× Denhardt's solution,1 mM sodium pyrophosphate, 50 mM Tris, pH 7.4, 0.1% SDS), denatured at 95°C for 5 min, incubated at 50°C for 5 min, and then centrifuged at 13,000 rpm for 5 min before being applied to an array. Hybridizations were performed under a cover slip at 42°C in a humidified oven for 16 h. Following hybridization, slides were washed twice in 2× SSC for 10 min and twice in 0.1× SSC for 5 min; all washes were performed at room temperature. After washing, slides were dried by centrifugation at 1000 rpm for 2 min.
Scanning and Analysis
Slides were scanned on a GenePix 4100 scanner (GRI) with 10 µm resolution and the TIFF images generated were analyzed using GenePix software. After image and grid alignment and spot location the GenePix results data file was imported to GeneSpring 6.1 software. Features whose mean signal intensity was less than four times the standard deviation of the local background pixel intensity were automatically flagged in GenePix. Manual flagging was also used to remove irregularities such as scratches and dust particles. Raw image data were extracted using Gene Pix Pro software. The Cy5 and Cy3 intensities were normalized against the value of the whole array using the LOWESS algorithm and the Cy5/Cy3 or Cy3/ Cy5 ratio was calculated for each spot. The normalized data were plotted to check the distribution of the experimental data. The groups of up-and downregulated genes were determined by identification of the genes that fall into the tails of the distribution plot. Hybridization experiments were repeated twice (with swapping of the labeled Cy3 and Cy5) using independent total RNA samples. Genes were considered as differentially expressed when both hybridizations showed >2-fold or <0.5-fold change. Data presented in this work represent the average of a total of four measurements from both hybridizations.
Validation of Gene Expression Profiles by Real-Time Quantitative PCR
The RT-qPCR (real-time quantitative PCR) system detects PCR products as they accumulate rather than assaying final product concentrations after a fixed number of cycles. The iCycler sequence detection system (Bio-Rad Laboratories, Hercules, CA) provides a way to monitor in real time the accumulation of DNA synthesized during the PCR process. It excites fluorescence of the selected dye and images the emitted light during each thermal cycle of the PCR run. To validate the relative gene expression levels by microarray analysis, we used RT-qPCR analysis to measure the expression levels of 11 genes in HM1 and K-ras Val12 ES cell-derived RNA. Briefly, 5 µg total RNA from wild-type ES cells was subjected to PCR with reverse transcription using the One Step RT-PCR kit (Gibco-BRL) according to the manufacturer's protocol to synthesize specific cDNA probes. PCRs were carried out for 32 cycles; each cycle consisted of a denaturing step for 1 min at 94°C, an an-nealing step for 2 min at 59°C, and a polymerization step for 2 min at 72°C. Selected RNA species were amplified using the following primers: human K-ras 4A transcript-sense (exon 3), 5′-AGT GCA ATG AGG GAC CAG TAC ATG AGG-3′ and antisense (exon 4A), 5′-TTG CTG ATG TTT CAA TAA AAG GAA TT-3′; human K-ras 4B transcript-sense (exon 3), primer the same as the K-ras 4A sense primer, and antisense (exon 4B), 5′-CTG CTT TCT GCC AAA ATT AAT GTG CTG-3′; Trap1a-sense, 5′-AAG AAT TGG AGA ACC TGA TGG A-3′ and antisense, 5′-GGG TCG TGG AAG AAA TAA ATC A-3′; Grb10-sense, 5′-GTT TAC AAA AGT CAC TGT GTG GAT G-3′ and antisense, 5′-CTC GTA CTT CGC ATA ATT CTT TCT G-3′; Pem-sense, 5′-GAG TCA AGG AAG ACT CGG AAG A-3′ and antisense, 5′-GGC CTT TTC CTC CAT TTA ATT C-3′; Syntaxin-sense, 5′-TGA CCT TGA ACA GCT CAC AAC-3′ and antisense, 5′-TGT CAT CAC CTC CAC AAA CTT C-3′; Snca-sense, 5′-CTA AGG AAG GAG TGG TTC ATG G-3′ and antisense, 5′-ATC TGG TCC TTC TTG ACA AAG C-3′; K-ras (exon 3)-sense, 5′-CTA CAG GAA GCA AGT AGT AAT TGA TGG-3′ and antisense, 5′-TGG TGA ATA TCT TCA AAT GAT TTA GT-3′; β-actin-sense, 5′-AAG CTG TGC TAT GTT GCT CTA GAC T-3′ and antisense, 5′-CAC TTC ATG ATG GAA TTG AAT GTA G-3′; Ccng-sense, 5′-GTG TTG GAG AAA GTG TGT TGG A-3′ and antisense, 5′-CAG AAG GCT TTG CCT TAG AAA A-3′; Rab14-sense, 5′AAT CTT GCT TGC TTC ATC AAT TTA C-3′ and antisense, 5′-AAC CAG CTG CTT AAG TGG TTA TAT G-3′; Anxa3-sense, 5′-CAG CAT TAA AGG AGA ATT ATC TGG A-3′ and antisense, 5′-AGA GAG TAG CCA TAG TGC TTC TTG A-3′; Mest-sense, 5′-GAT AGT TGT GCT TTT ACA TGG CTT T-3′ and antisense, 5′-AAC GAT ATC TCC ATA ATC GTG AGA C-3′; Adcy-sense, 5′-TCA CCT CTG AGT TTG AGA CCA A-3′ and antisense, 5′ -AAC TGT CCT GAC ACA GGG AGA T-3′; Tnfrsf9-sense, 5′-TGC TGC TAG TGG GCT GTG-3′ and antisense, 5′-AGG GGG TCC ACA CAC CAC-3′; 18S rRNA-sense, 5′-TGA CTC AAC ACG GGA AAC C-3′ and antisense, 5′-TCG CTC CAC CAA CTA AGA AC-3′. Ribosomal RNA (18S rRNA) and β-actin were used as internal controls. Total RNA (100 ng) of each sample was reverse transcribed in 25 ml volume using the iTaq SYBR Green kit RT-PCR kit (BioRad). All RT-qPCR reactions were amplified starting with denaturation at 95°C for 3 min, then 35 cycles of 95°C for 15 s and 60°C for 1 min. The specificity of the PCR reactions was determined from the dissociation curve analysis and 2% agarose gel electrophoresis. All PCR products were in the linear range of the exponential phase of PCR amplification. The quantity of the specific genes obtained from standard curves was normalized against that of the 18S rRNA of the same sample. All RT-qPCR reactions were performed in triplicate and the average value was calculated for the fold difference in expression levels as the ratio of the value of each sample normalized against the 18S rRNA for Kras Val12 ES cells relative to wild-type HM1 ES cells.
RESULTS
Comparison of the Expression Levels of Mutant K-ras
Val12 and Wild-Type K-ras RNA in the ES Cells
We designed PCR primers to hybridize equally effectively to exon 3 of wild-type murine K-ras and human K-ras
Val12 to generate PCR products with DNA sequences that are almost identical with just one base pair difference in the central part of the PCR product. We used semiquantitative and real-time PCR methods to compare the expression levels of mutant Kras
Val12
and wild-type K-ras RNA in the stem cell lines, after normalizing against the housekeeping gene β-actin RNA, to show that K-ras expression is 20% higher (1.2-fold) in the K-ras
-expressing ES cell line than wild-type K-ras in the control stem cells (Fig. 1) . This confirmed the microarray results, which showed that K-ras 4B was expressed 1.225-fold higher in the K-ras
Val12 ES cells relative to control cells. We also showed that the K-ras
Val12 cell line expressed both K-ras 4A and K-ras 4B transcripts by RT-PCR (Fig. 1 ). Previous analyses of several clones of ES cells with these genetic alterations to K-ras showed consistent phenotypic properties, in terms of apoptotic response and differentiation, and this reflected the genotype rather than clonal variation (9, 22) .
K-ras Val12 Inhibits ES Cell Differentiation
Mouse recombinant LIF can maintain totipotent ES cell lines in an undifferentiated state such that they retain the potential to form chimeric mice (44) . Undifferentiated murine ES cells can be maintained in vitro for extended periods in media containing the cytokine LIF. The undifferentiated state of ES cells can be characterized by high levels of expression of alkaline phosphatase. To assess the effect of K-ras Val12 on ES cell differentiation, both control and K-ras
Val12
expressing ES cells were cultured with various concentrations of LIF. After 6 days, the activity levels of alkaline phosphatase were measured. The data showed that for both 500 and 1000 U/ml LIF, activity levels of alkaline phosphatase showed no significant differences between K-ras LIF was decreased from 500 to 100 U/ml, the relative alkaline phosphatase activity levels of the K-ras
ES cells were mildly increased compared to control cells: 16.36 ± 0.90 (K-ras
) compared to 13.50 ± 1.29 (HM1). Importantly, when LIF was decreased to 10 U/ml, the relative alkaline phosphatase activity of the K-ras Val12 ES cells was markedly higher than that in the control cells: 13.96 ± 1.42 (K-ras
) compared to 6.43 ± 1.03 (HM1) (n = 6, p < 0.05) ( Fig.  2A) . This pattern was confirmed by directly counting undifferentiated colonies of ES cells after 6 days of treatment with 10, 100, or 500 U/ml LIF, by using alkaline phosphatase staining of the colonies of undifferentiated ES cells, carried out using BCIP/NBT solution. The results showed that the percentage of undifferentiated colonies was significantly higher for K-ras
-expressing ES cells compared to control HM1 ES cells: 93.33 ± 4.91% (K-ras
) compared to 84.86 ± 5.29% (controls) at 500 U/ml LIF (n = 6, p < 0.05); 67.42 ± 6.14% (K-ras
) compared to 34.74 ± 4.51% (controls) at 100 U/ml LIF (n = 6, p < 0.05); and 29.80 ± 3.51% (K-ras
) compared to 11.88 ± 1.64% (controls) at 10 U/ml LIF (n = 6, p < 0.05) (Fig. 2B ). These observations demonstrate that K-ras
Val12 enhances the effect of LIF to maintain selfrenewal of mouse ES cells in an undifferentiated state and this effect is most readily seen on withdrawal of LIF ( Fig. 2A, B) .
K-ras
Val12 Increases Susceptibility to DNA Damage-Induced ES Cell Apoptosis
Etoposide treatment of these cell lines resulted in a dose-dependent increase in apoptosis in both ES cell lines as measured flow cytometrically by evaluating the sub-G 0 /G 1 population (Fig. 3) . However, the levels of apoptosis at any given concentration of etoposide varied according to the K-ras status of the cells. K-ras Val12 ES cells showed higher levels of apoptosis compared to the control HM1 ES cells: when 
Analysis of the Changes in Gene Expression Induced by K-ras
Val12 Relative to Wild-Type Stem Cells
We used cDNA microarrays to compare gene expression profiles of K-ras
Val12
-expressing murine ES cells (without endogenous wild-type K-ras coexpression) with the parent normal ES cells that expressed wild-type K-ras. For all data points, we obtained four measurements derived from duplicate spots on arrays from two hybridizations. The data presented include only genes that show upregulated or downregulated expression of at least 2-fold compared to expression levels for that gene in wild-type ES cells (Fig. 4) . Among the ϳ15,000 genes and ESTs analyzed, 422 showed altered expression of at least 2-fold in the Kras
-expressing stem cells, compared to wild-type stem cells, of which 141 corresponded to ESTs. Among known genes showing changes in expression, 123 genes were upregulated, whereas 158 genes were downregulated (lists of upregulated and downregulated genes are available directly from the author at <mja40@cam.ac.uk> or from the website URL: xxx xxxxxxxxxxxxxxxxxxx). It is interesting to note that of those genes (showing greater than 2-fold changes in expression) that encoded transcription factors, signaling proteins, cell proliferation, or apoptosis-related proteins, approximately one half were upregulated, whereas the other half were downregulated in Kras
-expressing ES cells (Fig. 4) . Of those genes encoding secretory proteins, receptors, proteases, protease inhibitors, extracellular matrix components, and cytosolic proteins, most were downregulated, whereas of those genes encoding apoptosis-associated proteins, DNA-associated proteins, and cell growthrelated proteins, most were upregulated in K-ras
expressing ES cells (Fig. 4) .
Transcription Factors. Nineteen genes encoding transcription factors were upregulated and 19 downregulated in K-ras
-expressing ES cells relative to wild-type cells. The most strongly upregulated genes corresponded to the H2A histone family member Y (H2afy, 6.5-fold increase), mesoderm-specific transcript (Mest, 5.3-fold increase), and X-linked nuclear protein (Xnp, 3.3-fold increase), whereas among the most repressed genes were the bromodomain adjacent to zinc finger domain 1A (Baz1a, 5.6-fold decrease), Id2 protein (Id-2, 3.8-fold decrease), helix-loophelix DNA binding protein regulator (Id, 3.7-fold decrease), and the myelocytomatosis oncogene (Myc, 3-fold decrease).
Structural Proteins. Eight genes encoding structural proteins were found to be upregulated in the Kras
-expressing ES cells relative to wild-type cells, whereas 10 genes were downregulated. The most important upregulated genes were alpha actinin 4 (Actn4, 4.6-fold increase) and alpha globin gene (3.3-fold increase), whereas the most downregulated EXPRESSION CHANGES IN K-rasVal12 ES CELLS genes were tropomyosin 1, alpha (Tpm1, 15-fold decrease), cytokeratin endo A (14.2-fold decrease), and cytokeratin endo B (11-fold decrease).
Signaling Factors. Thirteen genes encoding proteins involved in various signaling pathways were upregulated and 13 downregulated in the K-ras
Val12
expressing ES cells relative to wild-type cells. The RAB14, member of the RAS oncogene family (Rab14) was found to be the most upregulated (12-fold increase); however, mitogen-activated protein kinase kinase kinase 12 (MAP3K12, 2.6-fold increase), Rho-associated coil-coil forming kinase 1 (Rock1, 2.5-fold increase), and phosphatidylinositol 3-kinase catalytic subunit delta (PI3Kcd, 2-fold increase) were also upregulated. In contrast, the NACHT, LRR and PYD containing protein 9b (NALP9b, 4.2-fold decrease) and integrin linked kinase (Ilk, 3.8-fold decrease) were the most strongly downregulated genes.
Receptors. Only two genes encoding receptors were upregulated in the K-ras
Val12
-expressing ES cells relative to wild-type cells, which were the aryl-hydrocarbon receptor (Ahr, 2.4-fold increase) and vanilloid receptor-like protein 1 (Vrl1, 2-fold increase). However, there were 13 genes downregulated and of these the most downregulated were the genes encoding insulin-like growth factor binding protein 3 (Igfbp3, 14.2-fold decrease), insulin-like growth factor 2 (Igf2, 7.7-fold decrease), growth hormone receptor (Ghr, 5.6-fold decrease), and growth factor receptor bound protein 10 (Grb10, 5.6-fold decrease).
Transporter Proteins. Six genes encoding transporter proteins were found to be upregulated in the K-ras
-expressing ES cells relative to wild-type cells. The most upregulated genes were those encoding tocopherol (alpha) transfer protein (Ttpa, 3.2-fold increase) and karyopherin (importin) alpha 3 (Kpna3, 2.7-fold increase). Nine genes encoding transporter proteins were found to be downregulated; solute carrier family 40 (iron-regulated transporter) member 1 (Slc40a1, 5.6-fold decrease), syntaxin 3 (Stx3, 3.8-fold decrease), and lysosomal-associated protein transmembrane 5 (Laptm5, 3.3-fold decrease) were the most strongly downregulated genes.
DNA, RNA, and Protein Binding Proteins. DNA, RNA, and protein binding proteins are involved in numerous biological processes. A total of 15 genes encoding such binding proteins were found to be upregulated in the K-ras
-expressing ES cells relative to wild-type cells. The most upregulated genes included 26S proteasome-associated pad1 homolog (Poh1-pending, 2.8-fold increase), ATP-binding cassette, sub-family B (MDR/TAP), member 7 (3.5-fold increase), and RNA-binding protein isoform G3BP-2a (G3BP2, 2.8-fold increase). Twenty-six genes encoding binding proteins were found to be downregulated, among which the genes encoding inhibitor of DNA binding 3 (Idb3, 5.6-fold decrease), calcium binding protein A6 (calcyclin) (S100a6, 5.6-fold decrease), caveolin, caveolae protein (Cav, 5-fold decrease), ephrin A5 (Efna5, 5-fold decrease), and highmobility group AT-hook 2 (Hmga2, 3-fold decrease) were the most strongly downregulated genes.
Enzymes. Thirteen enzymes involved in cellular metabolism were found to be overexpressed in the Kras
-expressing ES cells relative to wild-type cells and 23 were found to be downregulated. The most upregulated genes were glutaredoxin 1 (Glrx1, 4.3-fold increase), phosphodiesterase 8A (Pde8a, 3.6-fold increase), and fatty acid coenzyme A ligase (Fac12, 2.8-fold increase), whereas the most repressed genes were calpain 2 (Capn2, 7.2-fold decrease), heparan sulfate 6-O-sulfotransferase 2 (Hs6st2, 7.1-fold decrease), retinol dehydrogenase 10 (Rdh10, 5-fold decrease), and ubiquinol-cytochrome c reductase core protein 1 (Uqcrc1, 4.8-fold decrease).
Proteases and Protease Inhibitors. Among genes encoding proteases and protease inhibitors, only the serine protease inhibitor 4 (Spi4, 2-fold increase) and ubiquitin specific protease 28 (Usp28, 2-fold in-EXPRESSION CHANGES IN K-rasVal12 ES CELLS 9 crease) were upregulated in the K-ras
-expressing ES cells relative to wild-type cells. Four genes encoding proteases and protease inhibitors were found to be repressed, including serine protease inhibitor 6 (Spi6, 3.1-fold decrease) and ubiquitin specific protease 14 (Usp14, 2.9-fold decrease), which were the most downregulated.
Membrane Proteins. Only three genes encoding membrane proteins were upregulated and three were downregulated in the K-ras
-expressing ES cells relative to wild-type cells. The T-cell immunoglobulin and mucin domain containing 2 (Timd2, 6.7-fold increase) and gap junction membrane channel protein beta 3 (Gjb3, 4.3-fold increase) were the most overexpressed genes, whereas coagulation factor III (F3)-tissue factor (F3, 7.7-fold decrease) and adipose differentiation related protein (Adfp, 4.5-fold decrease) were the most repressed.
Cytosolic Proteins. Five genes encoding cytosolic proteins were found to be upregulated in the Kras
-expressing ES cells relative to wild-type cells, whereas nine such genes were downregulated. The most upregulated genes were prolactin-like protein A (Prlpa, 3-fold increase) and heat shock protein 65 (Hsp65, 2.2-fold increase), whereas the most repressed genes were prion protein (Prnp, 4.5-fold decrease), low density lipoprotein receptor-related protein 2 (Lrp2, 4-fold decrease), and lectin, galactose binding, soluble 1 (Lgals1, 3.6-fold decrease).
Extracellular Matrix Proteins.
No genes encoding extracellular matrix proteins were found to be upregulated in the K-ras
Val12 expressing ES cells relative to wild-type cells, whereas 12 such genes were found to be downregulated; among them were genes for annexin A3 (Anxa3, 14.2-fold decrease), keratin complex 1, acidic, gene 18 (Krt1-18, 10-fold decrease), keratin complex 1, acidic, gene 19 (Krt1-19, 6.7-fold decrease), desmocollin 2 (Dsc2, 6.7-fold decrease), and annexin A1 (Anxa1, 6.3-fold decrease), which were the most repressed.
Cell Growth-Associated Proteins. Twenty-two genes encoding cell growth-associated proteins were upregulated in the K-ras
Val12
-expressing ES cells relative to wild-type cells. The most strongly upregulated genes were T-cell lymphoma breakpoint 1 (Tcl1, either 6-fold increase or 4.3-fold increase according to the two different cDNA clones spotted on the microarray), clone L14 variable group of 2-cell-stage gene family (5-fold increase), tumor rejection antigen P1A (Trap1a, 4.3-fold increase), and tumor protein D52-like 1 (Tpd52l1, 4-fold increase). Sixteen genes encoding cell growth-associated proteins were downregulated; the most strongly repressed gene were stratifin (Sfn, 5.6-fold decrease), LIM domain containing preferred translocation partner in lipoma (Lpp, 4.2-fold decrease), and cyclin D2 (Ccnd2, 3.7-fold decrease).
Apoptosis-Related Proteins. Two apoptosisrelated genes were found to be upregulated in the Kras
-expressing ES cells relative to wild-type cells and six such genes were downregulated. The tumor necrosis factor receptor superfamily, member 9 (Tnfrsf9, 2.8-fold increase) and BCL2/adenovirus E1B 19 kDa-interacting protein 1, NIP3 (Bnip3, 2.3-fold increase) were upregulated genes, and tumor necrosis factor receptor superfamily, member 12a (Tnfrsf12a, 5.6-fold decrease), TF-1 cell apoptosis related protein-15 (Tfar15, 3-fold decrease), and craniofacial development protein 1 (Cfdp, 2.9-fold decrease) were the most underexpressed genes.
Genes of Unknown Function and ESTs. Seventyfour genes and ESTs of unknown function were found to be upregulated in the K-ras
Val12
-expressing ES cells relative to wild-type cells and 67 were found to be downregulated (lists of upregulated and downregulated genes are available directly from the author at <mja40@cam.ac.uk> or from the website URL: xxxxxxxxxxxxxxxxxxxxxx). These findings indicate that besides the known genes, there are more unknown genes likely to have altered expression levels as a result of K-ras Val12 expression.
Validation of Microarray-Determined Levels of Gene Expression by Real-Time Quantitative PCR
We verified the relative expression levels of 11 genes in the ES cells by reverse transcription-PCR and real-time quantitative PCR (RT-qPCR) analysis (Fig. 5, Table 1 ). These genes were selected according to their changes in expression levels (five upregulated genes, five downregulated genes, and one unchanged gene) and they were tested by RT-qPCR to validate changes in relative gene expression levels determined by the microarray experiments. The genes analyzed in this way encoded tumor rejection antigen P1A (Trap1a), alpha-placentae and embryo oncofetal gene (Pem), growth factor receptor bound protein 10 (Grb10), Syntaxin, a member of the ras oncogene family (Rab14), mesoderm-specific transcript (Mest), T-cell lymphoma breakpoint (Tcl1), cyclin G (Ccng), annexin A3 (Anxa3), alpha-synuclein (Snca), and β-actin. In all of the genes tested, the relative levels (compared to 18S rRNA levels) of gene expression (comparing K-ras
Val12
-expressing ES cells with wild- type ES cells) were determined by real-time quantitative PCR. These relative expression levels (RT-qPCR Fold) showed strong correlations with the relative expression levels measured by microarray hybridization (Array Fold). For those downregulated genes, the Pearson correlation of RT-qPCR Fold and Array Fold was 0.975 (p = 0.005); for those upregulated genes the Pearson correlation of RT-qPCR Fold and Array Fold was 0.935 (p = 0.020); both down-and up regulated genes together showed a Pearson correlation of R = 0.906 (p < 0.0001) (Fig. 6) . The relative expression levels in murine intestinal tissues of a subset of these genes were similarly ana- showed upregulation of tumor rejection antigen P1A (Trap) by 2.88-fold, alpha-placentae and embryo oncofetal gene (Pem) by 1.47-fold, mesoderm-specific transcript (Mest) by 1.97-fold, T-cell lymphoma breakpoint (Tcl1) by 4.17-fold, member 14 of the RAS oncogene family (Rab14) by 12.87-fold; and downregulation of annexin A3 (Anxa3) by 9.80-fold, alpha-synuclein (Snca) by 2.75-fold, cyclin G1 (Ccng) by 2.31-fold, and growth factor receptor bound protein 10 (Grb10) by 1.94-fold (29) . For both down-and upregulated genes together there was a Pearson correlation of R = 0.91 (p < 0.01) comparing in vivo intestinal expression by RT-qPCR with ES cell line microarray hybridization data (Fig. 6 ).
DISCUSSION
We set out to study changes in expression of target genes induced by K-ras
Val12 in order to improve understanding of the roles of oncogenic K-ras in carci-nogenesis. A number of ras-modulated genes have been previously identified by studies on immortalized cells or cancer cell lines manipulated to express oncogenic ras genes (8, 19, 23, 24, 27, 36) . However, such cell lines are frequently subject to multiple genetic and epigenetic changes that are selected during cancer formation or immortalization, and these are likely to affect the type and number of target genes modulated and their expression levels. In contrast, murine embryonic stem cells do not have this drawback, which is why we decided to analyze global gene expression changes in K-ras
Val12
-expressing ES cells relative to wild-type ES cells. We chose K-ras, rather than H-ras or N-ras, because K-ras is the most frequently mutated member of the ras gene family in human cancers. We knocked out both alleles of the endogenous murine wild-type K-ras prior to transfection with an expression vector for K-ras
, so that there would be no interference with the effects of the K-ras
Val12 encoded proteins in the ES cells by competing wild-type K-Ras proteins, a situation that can also be found in some human cancers (32, 33) . We demonstrated that the K-ras Val12 minigene is expressed at levels close to (only 1.2-fold) those of endogenous K-ras in wild-type ES cells. We showed that the Kras Val12 minigene allowed expression of transcripts for both K-Ras4A and K-Ras4B protein isoforms in order to more closely recapitulate the conditions in neoplastic cells in which endogenous K-ras is mutated and both isoforms may be expressed (31) (32) (33) . There were almost no changes in expression levels of H-ras (1.03-fold) and N-ras (1.01-fold) or RasGAP (0.915-fold) transcripts in K-ras Val12 ES cells relative to control cells. Using microarray technology with a cDNA array containing ϳ15,000 genes and ESTs, we found that expression of 3.4% of them was modified in the K-ras
-expressing ES cells relative to wild-type ES cells. These microarray data were validated by realtime quantitative reverse-transcription analysis of expression of a panel of selected genes (up-and downregulated) that showed very good correlations (R > 0.9), which were statistically significant, for these ES cell lines in vitro and also for a subset of the genes in vivo using K-ras Val12 /Cre mice with inducible expression of K-ras V12 in the stem cells of intestinal crypts (21, 29) . In particular, we wished to investigate whether there were changes in expression to genes that may influence three of the key phenotypic changes of neoplasia shown to be modulated by oncogenic K-ras in this cell line: apoptosis, differentiation, and proliferation (9, 22) .
Data presented here and previously for this Kras
-expressing ES cell line have showed that mutant K-ras increases the susceptibility to apoptosis after certain forms of DNA damage in vitro and during tumor growth as teratomas in vivo (9, 22) . This phenotypic effect on apoptosis may be explained, at least in part, by altered regulation of genes encoding apoptosis-associated proteins, such as upregulation of BNip3, which belongs to the group of proapoptotic genes (14) and upregulation of interferon regulatory factor-1 (IRF-1), which induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo (25) . K-ras
Val12 expression induced downregulation of Cfdp, which is usually necessary for cell survival (15) . K-ras
Val12 expression mediated downregulation of Clu, the silencing of which increases apoptotic sensitivity to genotoxic stress (39) . A mild reduction in expression of gelsolin (by 1.85-fold lower relative to control cells) was observed in K-ras
-expressing ES cells, consistent with the findings of Klampfer, who showed that oncogenic K-ras promotes butyrate-induced apoptosis by inhibition of gelsolin expression. Differences in the levels of gelsolin downregulation may reflect the different cell types studied, but the common direction of change confirms this finding (26) . Other relevant changes include a small increase in p53 transcript levels (1.32-fold higher) and a reduction in Mdm2 RNA levels (0.491-fold) in Kras Val12 ES cells relative to control cells. Such gene expression changes, brought about by K-ras
expression, are consistent with K-ras
Val12 increasing the susceptibility of ES cells to apoptosis.
Cancers derive from tissue stem cells and may harbor "cancer stem cells" that determine growth rate and differentiation patterns (2) . Data presented here and previously for this K-ras
Val12
-expressing ES cell line showed that mutant K-ras decreases differentiation of the stem cells both in vivo and in vitro while increasing self-renewal of undifferentiated, alkaline phosphatase-positive, stem cells (22) . This phenotypic effect may be explained, at least in part, by changes in expression to certain target genes, including upregulation of four stem cell-associated genes: mesoderm-specific transcript (Mest), Nanog homeobox (Nanog), placentae and embryos oncofetal gene (Pem), and clone L14 variable group of 2-cell-stage gene family. Nanog is a critical factor underlying pluripotency in both inner cell mass and ES cells, and upregulated expression of Nanog inhibits stem cell differentiation (30) . Pem blocks differentiation of embryonic stem cells (17) , and expression of Pem depends on the ras pathway, which could explain both its Ets-and Sp1-dependent expression in normal cells and its aberrant expression in tumor cells in which ras proto-oncogenes are frequently mutated (34) . These data support the hypothesis that mutant K-ras inhibits stem cell differentiation and may thus play a similar role in promoting self-renewal without differentiation in cancer stem cells.
It is well documented in a large range of studies that mutant K-ras increases proliferation or net growth of neoplastic cells (5, 6, 9, 22, 28) . This phenotypic effect may be explained, at least in part, by upregulation of certain genes encoding cell growthrelated proteins and DNA-associated proteins such as T-cell lymphoma breakpoint 1 (Tcl1), tumor rejection antigen P1A (Trap1a), myeloblastosis oncogene-like 2 (Mybl2), cell division cycle 5-like (S. pombe) (Cdc5l), and ras homolog gene family member G (Arhg), and downregulation of genes encoding Son cell proliferation protein (Son), insulin-like growth factor binding proteins 3 and 4 (Igfbp3 and Igfbp4), insulin-like growth factor 2 (Igf2), growth hormone receptor (Ghr), and growth factor receptor bound protein 10 (Grb10). There was altered expression of 49 enzymes involved in cell metabolism and these enzymes could play a supportive role in allowing increased growth, in particular genes encoding phosphoribosyl pyrophosphate synthetase 1 (Prps1) (43) and fatty acid-CoA ligase 4 (Fal4), which is involved in controlling the unesterified arachidonic acid (AA) levels in cells with promotion of colon carcinogenesis by lowering the cellular level of unesterified AA (10) .
Such changes suggest that K-ras
Val12 can bring about many changes in gene expression that collectively may support or promote cell proliferation in stem cells and there may be similar effects in carcinogenesis.
Several examples of gene up-or downregulation upon mutant ras transformation have previously been reported (13, 20, 36, 37) . We compared our gene expression data from K-ras Val12 expression in mouse ES cells with gene expression profiling data from H-rastransformed rat fibroblast cell lines (36) . Four genes (Psmd12, Aldh3a, Cald1, and Clu) of 70 listed upregulated genes show increased expression of more than 2-fold in both models; four genes (Akap2, Cbfb, Calm, and Mybbp1a) of 74 listed downregulated genes show decreased expression of more than 2-fold in both models. Interestingly, nine pairs of related genes, which belong to the same gene family (e.g., rock1 and rock2), out of 70 listed upregulated genes show increased expression in both models, whereas seven pairs of related family member genes of 74 listed downregulated genes show decreased expression in both models (e.g., Annexin 4 and Annexin 5). Possible reasons that may explain some of the differences between these two models include the cell lines being of different histogenetic type (embryonic stem cells vs. fibroblasts), derivation from different species (mice vs. rats), and transformation by different mutated gene members of the same ras gene family (K-ras vs. H-ras). The data presented here on the systematic analysis of about one half of the expressed mouse genome confirm some of the findings of these earlier reports while extending considerably our knowledge of genes upregulated or repressed by oncogenic K-ras in otherwise normal stem cells. Several genes coding for transcription factors and proteins involved in signaling pathways were up-or downregulated in the K-ras
Val12
-expressing ES cells. It is interesting to note that approximately as many transcription factors were upregulated (n = 19) as downregulated (n = 19), indicating a complex web of pleiotropic effects brought about by mutant K-ras. In conclusion, this study of approximately one half of the mouse transcriptome has identified a large number of genes whose expression is altered by K-ras Val12 expression in murine ES cells in the absence of wildtype K-ras. However, this cannot be considered to be an exhaustive catalogue of genes showing biologically significant altered expression, because not only do the genes analyzed on the microarray only represent around one half of the genome, but also the effects of posttranscriptional and posttranslational modifications were not addressed. However, this large volume of information gathered is likely to be useful for guiding stem cell processes and future investigation of some of the molecular mechanisms of oncogenic K-ras-mediated effects on neoplasia.
